Gland Pharma Approves Grant of 5.90 Lakh Stock Options Under ESOP 2025
Gland Pharma Ltd 路 Others (Uncategorized) 路 13 Sept 2026, 9:04 pm
Gland Pharma Approves Grant of 5.90 Lakh Stock Options Under ESOP 2025 Gland Pharma's ESOP Compensation Committee approved the grant of 5,90,249 stock options to 124 employees under the ESOP 2025 scheme on 13th Sep'26. The grant comprises 3,89,564 options priced at INR 1,461.15 per share (50% of the NSE closing price on 11th Sep'26) and 2,00,685 options at a face value of INR 1 per share. The options follow a three-year vesting schedule: 34% on 13th Sep'27, 33% on 13th Sep'28, and 33% on 13th Sep'29, exercisable within two years from each vesting date.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
